GB1152677A - Improved Anabolic Agent - Google Patents

Improved Anabolic Agent

Info

Publication number
GB1152677A
GB1152677A GB52249/66A GB5224966A GB1152677A GB 1152677 A GB1152677 A GB 1152677A GB 52249/66 A GB52249/66 A GB 52249/66A GB 5224966 A GB5224966 A GB 5224966A GB 1152677 A GB1152677 A GB 1152677A
Authority
GB
United Kingdom
Prior art keywords
suspensions
anabolic agent
solutions
anabolic
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB52249/66A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commercial Solvents Corp
Original Assignee
Commercial Solvents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commercial Solvents Corp filed Critical Commercial Solvents Corp
Publication of GB1152677A publication Critical patent/GB1152677A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,152,677. Anabolic agents. COMMERCIAL SOLVENTS CORP. 22 Nov., 1966 [7 Dec., 1965], No. 52249/66. Heading A5B. Pharmaceutical compositions in dosage unit form having anabolic activity comprise in admixture with a pharmaceutically acceptable carrier, from 0.05 to 50 mgs of a compound having the structure wherein A is -CH 2- CH 2 - or -CH=CH- and Z is >C=O or >CHOH. Administration may be orally in the form of tablets, capsules, pills, syrups, solutions, suspensions or dispersible powders, or parenterally e.g. in the form of sterile aqueous solutions or suspensions in oil media, the various forms containing conventional excipients.
GB52249/66A 1965-12-07 1966-11-22 Improved Anabolic Agent Expired GB1152677A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51223665A 1965-12-07 1965-12-07

Publications (1)

Publication Number Publication Date
GB1152677A true GB1152677A (en) 1969-05-21

Family

ID=24038255

Family Applications (1)

Application Number Title Priority Date Filing Date
GB52249/66A Expired GB1152677A (en) 1965-12-07 1966-11-22 Improved Anabolic Agent

Country Status (4)

Country Link
BE (1) BE690836A (en)
FR (1) FR6612M (en)
GB (1) GB1152677A (en)
IL (1) IL26901A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321491A1 (en) * 1975-08-22 1977-03-18 Imc Chemical Group ZEARALENONE CHEMICAL REDUCTION PROCESS
US8674120B2 (en) 2009-04-09 2014-03-18 Intervet International B.V. Process for manufacturing zeranol

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321491A1 (en) * 1975-08-22 1977-03-18 Imc Chemical Group ZEARALENONE CHEMICAL REDUCTION PROCESS
US8674120B2 (en) 2009-04-09 2014-03-18 Intervet International B.V. Process for manufacturing zeranol

Also Published As

Publication number Publication date
BE690836A (en) 1967-05-16
IL26901A (en) 1970-06-17
FR6612M (en) 1969-01-13

Similar Documents

Publication Publication Date Title
GB1439625A (en) Compositions for reducing blood cholesterol
GB1152677A (en) Improved Anabolic Agent
GB1252286A (en)
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
GB1256723A (en)
GB1152674A (en) Improvements in or relating to the Prevention of Maturation of Spermatogenesis
GB1204172A (en) Pharmaceutical compositions
GB1152678A (en) Improvements in or relating to Estrogenic Therapy
ES8602654A1 (en) Medicines based on piperidine derivatives, piperidine derivatives and process for their preparation.
GB1126153A (en) Novel polygalacturonic acid derivative
GB1152676A (en) Improvements in or relating to the Prevention of Pregnancy
GB1280244A (en) Serum triglyceride-lowering compositions
GB1298587A (en) Methods of contraception and contraceptive compositions
GB1220793A (en) Pharmaceutical compositions
GB1174988A (en) Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
GB1173809A (en) N-Substituted Nor-Morphines
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone
GB1091109A (en) New derivative of phenylbutazone and its preparation
GB909879A (en) Improvements in or relating to the manufacture of derivatives of nitrofuran
GB1125924A (en) Organic bismuth derivative
GB1375847A (en)
GB1247783A (en) Production of indole acetaldehydes
GB1457950A (en) Antibacterial compositions
GB1272452A (en) Pharmaceutical preparations comprising a thioacetamide derivative

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee